| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 7e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |